Arnaud Bastien

1.6k total citations · 1 hit paper
15 papers, 1.2k citations indexed

About

Arnaud Bastien is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Arnaud Bastien has authored 15 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Arnaud Bastien's work include Health Systems, Economic Evaluations, Quality of Life (3 papers), Diabetes Treatment and Management (3 papers) and Cardiomyopathy and Myosin Studies (3 papers). Arnaud Bastien is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (3 papers), Diabetes Treatment and Management (3 papers) and Cardiomyopathy and Myosin Studies (3 papers). Arnaud Bastien collaborates with scholars based in United States, Canada and Belgium. Arnaud Bastien's co-authors include James F. List, Anne Pieters, Clifford J. Bailey, Jorge Luiz Gross, Caroline T'joen, Paul Norwood, John Wilding, Fred T. Fiedorek, John E. Gerich and Barry R. Davis and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Diabetes Care.

In The Last Decade

Arnaud Bastien

14 papers receiving 1.1k citations

Hit Papers

Effect of dapagliflozin in patients with type 2 diabetes ... 2010 2026 2015 2020 2010 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial
    2010 708 citations Clifford J. Bailey, Jorge Luiz Gross et al. The Lancet profile →

Peers

Arnaud Bastien
Francis C. C. Chow Hong Kong
Heidrun Bosch‐Traberg Denmark
Nicole Vaccaro United States
Paul Strumph United States
Søren S. Lund Germany
Andreas Holstein Germany
Louise A. Donnelly United Kingdom
Irl B. Hirsch United States
Samuel S. Engel United States
Tami Sadusky United States
Francis C. C. Chow Hong Kong
Arnaud Bastien
Citations per year, relative to Arnaud Bastien Arnaud Bastien (= 1×) peers Francis C. C. Chow

Countries citing papers authored by Arnaud Bastien

Since Specialization
Citations

This map shows the geographic impact of Arnaud Bastien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnaud Bastien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnaud Bastien more than expected).

Fields of papers citing papers by Arnaud Bastien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnaud Bastien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnaud Bastien. The network helps show where Arnaud Bastien may publish in the future.

Co-authorship network of co-authors of Arnaud Bastien

This figure shows the co-authorship network connecting the top 25 collaborators of Arnaud Bastien. A scholar is included among the top collaborators of Arnaud Bastien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnaud Bastien. Arnaud Bastien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Myers, Michael C., et al.. (2025). Prevalence and Incidence of Dilated Cardiomyopathy in the United States and Western Europe: A Systematic Review. Cardiology Research. 16(4). 295–305. 1 indexed citations
2.
Spall, Harriette G.C. Van, Arnaud Bastien, Bernard J. Gersh, et al.. (2024). The role of early-phase trials and real-world evidence in drug development. Nature Cardiovascular Research. 3(2). 110–117. 3 indexed citations
3.
Myers, Michael C., Su Wang, Yue Zhong, et al.. (2024). Prevalence of Genetically Associated Dilated Cardiomyopathy: A Systematic Literature Review and Meta-Analysis. Cardiology Research. 15(4). 233–245. 2 indexed citations
4.
Desai, Milind Y., et al.. (2024). Mavacamten: Real-World Experience From 22 Months of the Risk Evaluation and Mitigation Strategy (REMS) Program. Circulation Heart Failure. 18(1). e012441–e012441. 9 indexed citations
5.
Martinez, Matthew W., et al.. (2024). Mavacamten. SHILAP Revista de lepidopterología. 4(1). 101430–101430. 1 indexed citations
6.
Myers, Michael C., et al.. (2024). Diverse Concepts in Definitions of Dilated Cardiomyopathy: Theory and Practice. Cardiology Research. 15(5). 319–329. 1 indexed citations
7.
Gerich, John E. & Arnaud Bastien. (2011). Development of the sodium-glucose co-transporter 2 inhibitor dapagliflozin for the treatment of patients with Type 2 diabetes mellitus. Expert Review of Clinical Pharmacology. 4(6). 669–683. 19 indexed citations
8.
Bailey, Clifford J., Jorge Luiz Gross, Anne Pieters, Arnaud Bastien, & James F. List. (2010). Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial. The Lancet. 375(9733). 2223–2233. 708 indexed citations breakdown →
9.
Wilding, John, Paul Norwood, Caroline T'joen, et al.. (2009). A Study of Dapagliflozin in Patients With Type 2 Diabetes Receiving High Doses of Insulin Plus Insulin Sensitizers. Diabetes Care. 32(9). 1656–1662. 316 indexed citations
10.
Nwachuku, Chuke, Arnaud Bastien, Jeffrey A. Cutler, et al.. (2008). Management of High Blood Pressure in Clinical Practice: Perceptible Qualitative Differences in Approaches Utilized by Clinicians. Journal of Clinical Hypertension. 10(11). 822–829. 7 indexed citations
11.
Cushman, William C., Charles E. Ford, Paula T. Einhorn, et al.. (2008). Blood Pressure Control by Drug Group in the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Journal of Clinical Hypertension. 10(10). 751–760. 70 indexed citations
12.
Sullivan, Mark D., Roger T. Anderson, David C. Aron, et al.. (2007). Health-Related Quality of Life and Cost-Effectiveness Components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Rationale and Design. The American Journal of Cardiology. 99(12). S90–S102. 25 indexed citations
13.
Bastien, Arnaud, Gillian L. Booth, Brenda Kirpach, et al.. (2007). Recruitment Strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial. The American Journal of Cardiology. 99(12). S68–S79. 28 indexed citations
14.
Rachoin, Jean-Sébastien, et al.. (2006). GLYCEMIC CONTROL DURING INHOSPITAL CORTICOSTEROID TREATMENT FOR EXACERBATIONS OF OBSTRUCTIVE AIRWAY DISEASE. CHEST Journal. 130(4). 184S–184S.
15.
Bastien, Arnaud. (1995). HIV in the inner cities: Epidemiologic trends and their influence on policy-making decisions. Journal of Community Health. 20(2). 177–181. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francis C. C. Chow Breakdown of academic impact, for papers by Heidrun Bosch‐Traberg Breakdown of academic impact, for papers by Nicole Vaccaro Breakdown of academic impact, for papers by Paul Strumph Breakdown of academic impact, for papers by Søren S. Lund Breakdown of academic impact, for papers by Andreas Holstein Breakdown of academic impact, for papers by Louise A. Donnelly Breakdown of academic impact, for papers by Irl B. Hirsch Breakdown of academic impact, for papers by Samuel S. Engel Breakdown of academic impact, for papers by Tami Sadusky
Rankless by CCL
2026